Fingerprint
Dive into the research topics of 'Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
Gregory A. Wiseman, Peter S. Conti, Katie Vo, Russell J. Schilder, Leo I. Gordon, Christos Emmanouilides, Dan H. Silverman, Thomas E. Witzig, Mohamed Darif, Arturo Molina
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations